

Court filings reveal that Medicaid patient data was improperly shared with ICE and subsequently forwarded to Palantir for use in its deportation tracking app, intensifying legal scrutiny of the company's government contracts.
| strategy | ticker | action | side | rationale |
|---|---|---|---|---|
| S1 | PLTR | ● enter | ▼ short | verdict FRESH, direction bearish -> sell PLTR (regulatory: Court filings reveal that Medicaid patient data was improperly shared with ICE and subsequently forwarded to Palantir for use in its deportation tracking app, intensifying legal scrutiny of the company's government contracts.) |
| S2 | - | ○ skip | — | no counterparty in universe |
| S3 | - | ○ skip | — | no peer in universe |
| S4 | PLTR | ● enter | ▼ short | overnight drift: sell PLTR at close, exit next close (regulatory: Court filings reveal that Medicaid patient data was improperly shared with ICE and subsequently forwarded to Palantir for use in its deportation tracking app, intensifying legal scrutiny of the company's government contracts.) |
| strategy | ticker | side | qty | entry | exit | P&L $ | status |
|---|---|---|---|---|---|---|---|
| S1 | PLTR | ▼ short | 7 | 131.65 | 132.68 | -7.21 | closed |
| S4 | PLTR | ▼ short | 7 | 132.70 | 124.41 | +58.03 | closed |
| ticker | mfe | mae | reflection |
|---|---|---|---|
| PLTR S1 | -0.65% | -2.20% | The entry logic was reasonable on paper — fresh regulatory news with legal-scrutiny implications — but the market shrugged: PLTR never traded meaningfully below entry (best excursion just -0.65%) and drifted against the short, suggesting this headline was either already priced in or immaterial to a stock driven by government-contract momentum. Regulatory noise around Palantir's government work is chronic, not novel, so "FRESH" verdicts on this news category are systematically overrated. Concrete fix: require a price-confirmation gate for regulatory-driven shorts — e.g., only enter if the stock is already down ≥1% on the session or breaks below a short-term low within N bars of the headline — otherwise downgrade the verdict to STALE and skip. |
| PLTR S4 | +6.93% | -0.45% | Retro note: The entry thesis (regulatory headline → overnight downside drift) played out almost perfectly — the stock fell ~6.2%, drawdown was negligible (-0.45%), and the exit captured nearly all of the max favorable move (+6.93%). This is the strategy working as designed, not luck to be over-fit on. Improvement: The rationale is qualitative ("intensifying legal scrutiny") — codify a severity threshold, e.g., only short on regulatory news that directly threatens revenue-generating contracts (as this one did) versus generic legal noise, and consider sizing up when the catalyst hits after-hours with no time for the market to price it in. Seven shares on a near-ideal setup is leaving money on the table if conviction can be scored mechanically. |